Successful management of bullous pemphigoid with dimethyl fumarate therapy: A case report()()()

A 69-year-old woman affected by multiple sclerosis for 35 years was diagnosed with bullous pemphigoid (BP) and treated successfully with dimethyl fumarate (DMF) at a dose of 120 mg twice per day for 7 days and then increased to 240 mg twice per day after first-line therapies of BP. DMF is now under...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilgic-Temel, Aslı, Das, Shilpa, Murrell, Dedee F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637068/
https://www.ncbi.nlm.nih.gov/pubmed/31360754
http://dx.doi.org/10.1016/j.ijwd.2019.02.001
_version_ 1783436167628193792
author Bilgic-Temel, Aslı
Das, Shilpa
Murrell, Dedee F.
author_facet Bilgic-Temel, Aslı
Das, Shilpa
Murrell, Dedee F.
author_sort Bilgic-Temel, Aslı
collection PubMed
description A 69-year-old woman affected by multiple sclerosis for 35 years was diagnosed with bullous pemphigoid (BP) and treated successfully with dimethyl fumarate (DMF) at a dose of 120 mg twice per day for 7 days and then increased to 240 mg twice per day after first-line therapies of BP. DMF is now under evaluation with an investigator-initiated prospective controlled trial in patients with BP to determine the efficacy and safety of adjuvant DMF. To our knowledge, this is the first case of BP successfully treated with DMF in the literature.
format Online
Article
Text
id pubmed-6637068
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-66370682019-07-29 Successful management of bullous pemphigoid with dimethyl fumarate therapy: A case report()()() Bilgic-Temel, Aslı Das, Shilpa Murrell, Dedee F. Int J Womens Dermatol Article A 69-year-old woman affected by multiple sclerosis for 35 years was diagnosed with bullous pemphigoid (BP) and treated successfully with dimethyl fumarate (DMF) at a dose of 120 mg twice per day for 7 days and then increased to 240 mg twice per day after first-line therapies of BP. DMF is now under evaluation with an investigator-initiated prospective controlled trial in patients with BP to determine the efficacy and safety of adjuvant DMF. To our knowledge, this is the first case of BP successfully treated with DMF in the literature. Elsevier 2019-02-22 /pmc/articles/PMC6637068/ /pubmed/31360754 http://dx.doi.org/10.1016/j.ijwd.2019.02.001 Text en © 2019 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Bilgic-Temel, Aslı
Das, Shilpa
Murrell, Dedee F.
Successful management of bullous pemphigoid with dimethyl fumarate therapy: A case report()()()
title Successful management of bullous pemphigoid with dimethyl fumarate therapy: A case report()()()
title_full Successful management of bullous pemphigoid with dimethyl fumarate therapy: A case report()()()
title_fullStr Successful management of bullous pemphigoid with dimethyl fumarate therapy: A case report()()()
title_full_unstemmed Successful management of bullous pemphigoid with dimethyl fumarate therapy: A case report()()()
title_short Successful management of bullous pemphigoid with dimethyl fumarate therapy: A case report()()()
title_sort successful management of bullous pemphigoid with dimethyl fumarate therapy: a case report()()()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637068/
https://www.ncbi.nlm.nih.gov/pubmed/31360754
http://dx.doi.org/10.1016/j.ijwd.2019.02.001
work_keys_str_mv AT bilgictemelaslı successfulmanagementofbullouspemphigoidwithdimethylfumaratetherapyacasereport
AT dasshilpa successfulmanagementofbullouspemphigoidwithdimethylfumaratetherapyacasereport
AT murrelldedeef successfulmanagementofbullouspemphigoidwithdimethylfumaratetherapyacasereport

Ejemplares similares